zithromax and Pericarditis

zithromax has been researched along with Pericarditis* in 4 studies

Reviews

1 review(s) available for zithromax and Pericarditis

ArticleYear
Left ventricular dysfunction in COVID-19: A diagnostic issue.
    Anaesthesia, critical care & pain medicine, 2020, Volume: 39, Issue:3

    Topics: Azithromycin; Betacoronavirus; Biomarkers; Coronavirus Infections; COVID-19; Cytokine Release Syndrome; Diagnosis, Differential; Drug Therapy, Combination; Humans; Hydroxychloroquine; Hypoxia; Long QT Syndrome; Myocardial Infarction; Myocarditis; Pandemics; Pericarditis; Pneumonia, Viral; SARS-CoV-2; Systemic Inflammatory Response Syndrome; Tachycardia, Ventricular; Thrombophilia; Ventricular Dysfunction, Left; Ventricular Fibrillation

2020

Other Studies

3 other study(ies) available for zithromax and Pericarditis

ArticleYear
Recurrent disseminated
    BMJ case reports, 2021, Jan-28, Volume: 14, Issue:1

    Anti-interferon-gamma (IFN-γ) autoantibodies has been recognised as an adult-onset immunodeficiency in the past decade in people who originate from Southeast Asia. These patients are susceptible to particular opportunistic infections, especially non-tuberculous mycobacteria (NTM). We present the case of a woman whom originally came from Thailand with disseminated

    Topics: Adult; Anti-Bacterial Agents; Asian People; Autoantibodies; Azithromycin; Bacteremia; Disease Progression; Ethambutol; Female; Humans; Immunologic Deficiency Syndromes; Immunologic Factors; Interferon-gamma; Mycobacterium avium Complex; Mycobacterium avium-intracellulare Infection; Pericarditis; Pleurisy; Pneumonia, Bacterial; Recurrence; Rifampin; Rituximab; Thailand

2021
Acute Myopericarditis Due to Campylobacter Jejuni.
    The American journal of medicine, 2020, Volume: 133, Issue:8

    Topics: Acute Disease; Anti-Bacterial Agents; Azithromycin; Campylobacter Infections; Campylobacter jejuni; Colchicine; Diarrhea; Electrocardiography; Female; Foodborne Diseases; Humans; Magnetic Resonance Imaging; Middle Aged; Myocarditis; Pericarditis; Troponin I; Tubulin Modulators

2020
Chlamydophila pneumoniae myopericarditis in a child.
    Pediatric cardiology, 2009, Volume: 30, Issue:3

    An 11-year-old boy with serologically confirmed Chlamydophila pneumoniae infection presented with clinical, laboratory, and echocardiographic changes consistent with myopericarditis. No reports on C. pneumoniae myopericarditis in children are found in the medical literature. The boy, previously healthy, presented with fever, rash, constitutional symptoms, elevated acute phase reactants, elevated cardiac enzymes, and high brain natriuretic peptide levels. Hemodynamic instabilities, including hypotension and mild hypoxia, were noted. Two-dimensional echocardiographic findings showed mildly depressed left ventricular systolic function and small pericardial effusion. Requiring inotropic support, the boy was treated with azithromycin 10 mg/kg once daily for 7 days and a single dose of intravenous immunoglobulin 2 g/kg. He recovered fully with improved left ventricular systolic function before hospital discharge. An early definitive diagnosis is essential to knowing the etiology of pediatric myocarditis. Specific therapy may play role in the management and prognosis of this disorder.

    Topics: Anti-Bacterial Agents; Antibodies, Bacterial; Azithromycin; Child; Chlamydophila Infections; Chlamydophila pneumoniae; Diagnosis, Differential; Drug Therapy, Combination; Echocardiography; Follow-Up Studies; Humans; Immunoglobulins, Intravenous; Immunologic Factors; Male; Myocarditis; Pericarditis; Tomography, X-Ray Computed

2009